{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:06:45Z","timestamp":1784552805798,"version":"3.55.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["308628\/2022\\u20135"],"award-info":[{"award-number":["308628\/2022\\u20135"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Minas Gerais State Foundation of Support to the Research","doi-asserted-by":"publisher","award":["APQ-00882-22"],"award-info":[{"award-number":["APQ-00882-22"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Finep","doi-asserted-by":"publisher","award":["1735\/22"],"award-info":[{"award-number":["1735\/22"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jneuroim.2026.578931","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T21:19:11Z","timestamp":1776028751000},"page":"578931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Functional immune responses to PI3K pathway inhibition in PBMCs from schizophrenia patients without metabolic syndrome"],"prefix":"10.1016","volume":"417","author":[{"given":"Vivian T.","family":"da Silveira An\u00edcio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid Caroline Silva","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9rica Leandro Marciano","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvina Maria","family":"de Campos-Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia Nat\u00e1lia","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle S.","family":"Mac\u00eado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Vin\u00edcius","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio Carlos Pinheiro","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2026.578931_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578931_bb0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S1516-44462000000300003","article-title":"Mini international neuropsychiatric interview (MINI): Valida\u00e7\u00e3o de entrevista breve para diagn\u00f3stico de transtornos mentais","volume":"22","author":"Amorim","year":"2000","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578931_bb0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2567.2010.03402.x","article-title":"Interleukin-10-induced gene expression and suppressive function are selectively modulated by the PI3K-Akt-GSK3 pathway","volume":"132","author":"Antoniv","year":"2011","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.jneuroim.2026.578931_bb0020","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.metabol.2013.07.001","article-title":"Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance","volume":"62","author":"Aroor","year":"2013","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.jneuroim.2026.578931_bb0025","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jpsychires.2013.05.032","article-title":"Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia","volume":"47","author":"Asevedo","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578931_bb0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-009-1551-2","article-title":"Early effects of mood stabilizers on the Akt\/GSK-3beta signaling pathway and on cell survival and proliferation","volume":"205","author":"Aubry","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578931_bb0035","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00213-017-4547-3","article-title":"Bi-phasic regulation of glycogen content in astrocytes via Cav-1\/PTEN\/PI3K\/AKT\/GSK-3\u03b2 pathway by fluoxetine","volume":"234","author":"Bai","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578931_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1503\/jpn.110011","article-title":"A role for akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health","volume":"37","author":"Beaulieu","year":"2012","journal-title":"J. Psychiatry Neurosci."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578931_bb0045","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","article-title":"An akt\/beta-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior","volume":"122","author":"Beaulieu","year":"2005","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578931_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ph14050446","article-title":"Cytokine level changes in schizophrenia patients with and without metabolic syndrome treated with atypical antipsychotics","volume":"14","author":"Boiko","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578931_bb0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000512082","article-title":"Cognition in schizophrenia: modeling the interplay between interleukin-1\u03b2 C-511T polymorphism, metabolic syndrome, and sex","volume":"80","author":"Bosia","year":"2021","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jneuroim.2026.578931_bb0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neubiorev.2017.03.003","article-title":"Acute variations of cytokine levels after antipsychotic treatment in drug-na\u00efve subjects with a first-episode psychosis: a meta-analysis","volume":"77","author":"Capuzzi","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2022.844383","article-title":"Schizophrenia hypothesis: autonomic nervous system dysregulation of fetal and adult immune tolerance","volume":"16","author":"Carnac","year":"2022","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148198","article-title":"Unravelling the genetic basis of schizophrenia","volume":"902","author":"Casey","year":"2024","journal-title":"Gene"},{"key":"10.1016\/j.jneuroim.2026.578931_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/srep25170","article-title":"A life course approach to explore the biological embedding of socioeconomic position and social mobility through circulating inflammatory markers","volume":"6","author":"Castagn\u00e9","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.578931_bb0080","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.4049\/jimmunol.141.11.3868","article-title":"Human t cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal","volume":"141","author":"Ceuppens","year":"1988","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.578931_bb0085","doi-asserted-by":"crossref","first-page":"6868","DOI":"10.1038\/s41380-021-01135-9","article-title":"MTOR kinase activity disrupts a phosphorylation signaling network in schizophrenia brain","volume":"26","author":"Chadha","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.jneuroim.2026.578931_bb0090","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2217\/imt.14.84","article-title":"MTOR signaling, tregs and immune modulation","volume":"6","author":"Chapman","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jneuroim.2026.578931_bb0095","series-title":"Immunopsychiatry: The Immunology of Psychiatric Disorders","first-page":"21","article-title":"Immunoneuropharmacology","author":"da Silveira","year":"2018"},{"issue":"23","key":"10.1016\/j.jneuroim.2026.578931_bb0100","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1523\/JNEUROSCI.0887-15.2015","article-title":"MTORC2\/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission","volume":"35","author":"Dadalko","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.comppsych.2017.01.008","article-title":"Serum levels of interleukin-33 and its soluble form receptor (sST2) are associated with cognitive performance in patients with schizophrenia","volume":"74","author":"de Campos-Carli","year":"2017","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jneuroim.2026.578931_bb0110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1590\/0047-2085000000344","article-title":"Patients and physicians self-assessment regarding clinical stability in severe mental disorders: a cross-sectional study","volume":"71","author":"de Oliveira","year":"2022","journal-title":"J. Bras. Psiquiatr."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578931_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/genes15030272","article-title":"Epigenetic regulation in schizophrenia: focus on methylation and histone modifications in human studies","volume":"15","author":"Delphin","year":"2024","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jneuroim.2026.578931_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2012.06.010","article-title":"Serum and gene expression profile of cytokines in first-episode psychosis","volume":"31","author":"Di Nicola","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jpsychires.2021.11.020","article-title":"Adiponectin and stnfr2 peripheral levels are associated with cardiovascular risk in patients with schizophrenia","volume":"149","author":"Dias","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578931_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41537-024-00469-x","article-title":"Association of cytokines levels, psychopathology and cognition among CR-TRS patients with metabolic syndrome","volume":"10","author":"Dong","year":"2024","journal-title":"Schizophrenia (Heidelb)."},{"issue":"1\u20133","key":"10.1016\/j.jneuroim.2026.578931_bb0135","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.schres.2008.03.018","article-title":"Patients with schizophrenia show raised serum levels of the pro-inflammatory chemokine CCL2: association with the metabolic syndrome in patients?","volume":"102","author":"Drexhage","year":"2008","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578931_bb0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1296","article-title":"Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia","volume":"36","author":"Emamian","year":"2004","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578931_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032215","article-title":"Chemokine dysregulation and neuroinflammation in schizophrenia: a systematic review","volume":"24","author":"Ermakov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0150","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2147\/NDT.S202159","article-title":"Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics","volume":"15","author":"Fang","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.602121","article-title":"Association between SIRT1, cytokines, and metabolic syndrome in schizophrenia patients with olanzapine or clozapine monotherapy","volume":"11","author":"Fang","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"15","key":"10.1016\/j.jneuroim.2026.578931_bb0160","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019694","article-title":"Effects of risperidone on blood levels of interleukin-6 in schizophrenia: a meta-analysis","volume":"99","author":"Feng","year":"2020","journal-title":"Med. (Baltimore)"},{"issue":"2\u20133","key":"10.1016\/j.jneuroim.2026.578931_bb0165","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.schres.2014.04.028","article-title":"Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia","volume":"156","author":"Ferretjans","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0170","article-title":"Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort","volume":"22","author":"Foiselle","year":"2022","journal-title":"Brain, Behavior, & Immunity"},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578931_bb0180","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1176\/appi.ajp.2009.08121873","article-title":"Roles of the Akt\/GSK-3 and wnt signaling pathways in schizophrenia and antipsychotic drug action","volume":"167","author":"Freyberg","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jneuroim.2026.578931_bb0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbi.2018.05.002","article-title":"Profiling inflammatory signatures of schizophrenia: a cross-sectional and meta-analysis study","volume":"71","author":"Frydecka","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115871","article-title":"Evidence for cytokine dysregulation in schizophrenia spectrum disorders: a comparison of cerebrospinal fluid and blood samples","volume":"335","author":"Gallego","year":"2024","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578931_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090407","article-title":"Association of interleukin-10 polymorphisms with schizophrenia: a meta-analysis","volume":"9","author":"Gao","year":"2014","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.jneuroim.2026.578931_bb0200","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578931_bb0205","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cyto.2013.07.022","article-title":"IL-17 family: cytokines, receptors and signaling","volume":"64","author":"Gu","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2026.578931_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.990874","article-title":"Akt isoforms in the immune system","volume":"13","author":"Guerau-de-Arellano","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.schres.2019.08.036","article-title":"Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT\/mTOR signaling as a pathological mediator of genetic and environmental programming during development","volume":"217","author":"Howell","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0220","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fphar.2020.00344","article-title":"Ribosomal protein s6 hypofunction in postmortem human brain links mTORC1-dependent signaling and schizophrenia","volume":"11","author":"Ibarra-Lecue","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.578931_bb0225","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s11064-018-2585-9","article-title":"Regulation of glycogen content in astrocytes via Cav-1\/PTEN\/AKT\/GSK-3\u03b2 pathway by three anti-bipolar drugs","volume":"43","author":"Jia","year":"2018","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578931_bb0230","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578931_bb0235","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.cmet.2016.05.009","article-title":"The mechanistic target of rapamycin: the grand ConducTOR of metabolism and aging","volume":"23","author":"Kennedy","year":"2016","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.578931_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081837","article-title":"Epigenomic dysregulation in schizophrenia: in search of disease etiology and biomarkers","volume":"9","author":"Khavari","year":"2020","journal-title":"Cells"},{"issue":"15","key":"10.1016\/j.jneuroim.2026.578931_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158263","article-title":"GSK3-driven modulation of inflammation and tissue integrity in the animal model","volume":"25","author":"K\u00fchl","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.jneuroim.2026.578931_bib501","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578931_bb0250","doi-asserted-by":"crossref","first-page":"13464","DOI":"10.1038\/s41598-017-12907-1","article-title":"Metabolic syndrome in rats is associated with erectile dysfunction by impairing PI3K\/Akt\/eNOS activity","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.jneuroim.2026.578931_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115503","article-title":"GSK3 as a master regulator of cellular processes","volume":"24","author":"Lichtinghagen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0260","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbi.2021.07.013","article-title":"Systemic inflammation and neuronal hyperexcitability: deciphering cellular neuropathology of sickness behaviour","volume":"97","author":"Lin","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"28","key":"10.1016\/j.jneuroim.2026.578931_bb0265","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.2174\/1381612820666140522115801","article-title":"Impact of MCP-1 in atherosclerosis","volume":"20","author":"Lin","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578931_bb0270","first-page":"287","article-title":"Pretreatment serum MCP-1 level predicts response to risperidone in schizophrenia","volume":"29","author":"Lin","year":"2017","journal-title":"Shanghai Arch. Psychiatry"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578931_bb0275","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.neuron.2014.09.034","article-title":"The neurology of mTOR","volume":"84","author":"Lipton","year":"2014","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.jneuroim.2026.578931_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112488","article-title":"A Meta-analysis of the influence of antipsychotics on cytokines levels in first episode psychosis","volume":"10","author":"Marcinowicz","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1\u20133","key":"10.1016\/j.jneuroim.2026.578931_bb0285","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2012.03.004","article-title":"Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes","volume":"137","author":"Mart\u00ednez-Cengotitabengoa","year":"2012","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578931_bb0290","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","article-title":"Schizophrenia-An overview","volume":"77","author":"McCutcheon","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578931_bb0295","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/cob.12107","article-title":"Educational level and chronic inflammation in the elderly--the role of obesity: results from the population-based CARLA study","volume":"5","author":"Medenwald","year":"2015","journal-title":"Clin. Obes."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578931_bb0300","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578931_bb0305","first-page":"7","article-title":"Human t lymphocytes stimulated by phytohaemagglutinin undergo a single round of cell division without a requirement for interleukin-2 or accessory cells","volume":"60","author":"Mire-Sluis","year":"1987","journal-title":"Immunology"},{"key":"10.1016\/j.jneuroim.2026.578931_bb0310","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3389\/fpsyt.2019.00892","article-title":"Cytokine alterations in schizophrenia: an updated review","volume":"10","author":"Momtazmanesh","year":"2019","journal-title":"Front. Psych."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109901","article-title":"Conditional GSK3\u03b2 deletion in parvalbumin-expressing interneurons potentiates excitatory synaptic function and learning in adult mice","volume":"100","author":"Monaco","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.jneuroim.2026.578931_bb0320","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.celrep.2017.11.014","article-title":"Noncanonical pathway for regulation of CCL2 expression by an mTORC1-FOXK1 axis promotes recruitment of tumor-associated macrophages","volume":"21","author":"Nakatsumi","year":"2017","journal-title":"Cell Rep."},{"issue":"25","key":"10.1016\/j.jneuroim.2026.578931_bb0325","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection Ea, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578931_bb0330","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jaci.2019.03.017","article-title":"PI3K pathway defects leading to immunodeficiency and immune dysregulation","volume":"143","author":"Nunes-Santos","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4\u20135","key":"10.1016\/j.jneuroim.2026.578931_bb0335","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0171-2985(86)80066-3","article-title":"Stimulation of human lymphocytes by phytohemagglutinin (PHA) in a new ultra-microtest plate","volume":"171","author":"Ocklind","year":"1986","journal-title":"Immunobiology"},{"key":"10.1016\/j.jneuroim.2026.578931_bb0340","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbi.2021.05.021","article-title":"In vivo mechanisms of cortical network dysfunction induced by systemic inflammation","volume":"96","author":"Odoj","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.jneuroim.2026.578931_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13092308","article-title":"Linking metabolic disorders and immune system phenomena in schizophrenia: the role of adipose tissue and inflammation","volume":"13","author":"Oracz","year":"2025","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578931_bb0350","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/01.ypg.0000128764.07344.06","article-title":"Monocyte chemoattractant protein-1 promoter \u22122518 polymorphism and schizophrenia in the korean population","volume":"14","author":"Pae","year":"2004","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122116","article-title":"Mitochondrial transfer restores impaired liver functions by AMPK\/ mTOR\/PI3K-AKT pathways in metabolic syndrome","volume":"332","author":"Paliwal","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0360","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.schres.2017.04.043","article-title":"Abnormal gene and protein expression of inflammatory cytokines in the postmortem brain of schizophrenia patients","volume":"192","author":"Pandey","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0365","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jpsychires.2023.01.042","article-title":"Anti-inflammatory effects of 2nd generation antipsychotics in patients with schizophrenia: a systematic review and meta-analysis","volume":"160","author":"Patlola","year":"2023","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578931_bb0370","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jpsychores.2015.06.011","article-title":"Cytokine profile in drug-na\u00efve, first episode patients with psychosis","volume":"79","author":"Petrikis","year":"2015","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0375","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbi.2019.12.007","article-title":"In vivo characterization of functional states of cortical microglia during peripheral inflammation","volume":"87","author":"Riester","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.jneuroim.2026.578931_bb0380","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/ijnp\/pyy062","article-title":"Kinetics of cytokine levels during antipsychotic treatment in schizophrenia: a meta-analysis","volume":"21","author":"Romeo","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578931_bb0385","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/bbrc.1999.0796","article-title":"A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression","volume":"259","author":"Rovin","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2025.116557","article-title":"Pro-inflammatory processes and metabolic syndrome: combined risk of resistance to treatment in patients with schizophrenia from the FACE-SZ cohort","volume":"350","author":"Saitoh","year":"2025","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0395","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4042615","article-title":"Protective effect of the MCP-1 gene haplotype against schizophrenia","volume":"2019","author":"Saoud","year":"2019","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0400","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fmolb.2017.00096","article-title":"Perspectives on systems modeling of human peripheral blood mononuclear cells","volume":"4","author":"Sen","year":"2017","journal-title":"Front. Mol. Biosci."},{"issue":"Pt B","key":"10.1016\/j.jneuroim.2026.578931_bb0405","article-title":"MCP-1: function, regulation, and involvement in disease","volume":"101","author":"Singh","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0410","series-title":"Proceedings of the 6th International Conference on Neuroscience, Neurology and Psychiatry (ICONAP 2023)","first-page":"1","article-title":"Association of the MCP-1 -2518 a\/G polymorphism with schizophrenia risk: Insights from a Batak ethnic group study","volume":"71","author":"Sinurat","year":"2023"},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578931_bb0415","first-page":"378","article-title":"Metabolic syndrome in schizophrenia - who is more to blame: FGA polypharmacy or clozapine monotherapy?","volume":"27","author":"Softic","year":"2015","journal-title":"Psychiatr. Danub."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578931_bb0420","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7150\/ijms.13800","article-title":"Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the west virginian population","volume":"13","author":"Srikanthan","year":"2016","journal-title":"Int. J. Med. Sci."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.578931_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112774","article-title":"MTOR and aging: an old fashioned dress","volume":"20","author":"Stallone","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.578931_bb0430","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.amjcard.2008.05.055","article-title":"Relation of educational level to inflammation-sensitive biomarker level","volume":"102","author":"Steinvil","year":"2008","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578931_bb0435","first-page":"104","article-title":"Schizophrenia causes significant burden to patients\u2019 and caregivers\u2019 lives","volume":"28","author":"Szkultecka-D\u0119bek","year":"2016","journal-title":"Psychiatr. Danub."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578931_bb0440","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","article-title":"Regulation and metabolic functions of mTORC1 and mTORC2","volume":"101","author":"Szwed","year":"2021","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578931_bb0445","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.pnpbp.2007.11.019","article-title":"Increased serum levels of CCL11\/eotaxin in schizophrenia","volume":"32","author":"Teixeira","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jneuroim.2026.578931_bb0450","doi-asserted-by":"crossref","first-page":"11","DOI":"10.12703\/r\/11-11","article-title":"Recent advances in understanding\/management of premenstrual dysphoric disorder\/premenstrual syndrome","volume":"11","author":"Tiranini","year":"2022","journal-title":"Fac Rev."},{"issue":"1\u20133","key":"10.1016\/j.jneuroim.2026.578931_bb0455","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2013.10.011","article-title":"Antipsychotics\u2019 effects on blood levels of cytokines in schizophrenia: a meta-analysis","volume":"151","author":"Tourjman","year":"2013","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578931_bb0460","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000505099","article-title":"Interleukin-6: a masterplayer in the cytokine network","volume":"98","author":"Uciechowski","year":"2020","journal-title":"Oncology"},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578931_bb0465","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/jcb.30433","article-title":"An insight into PI3k\/Akt pathway and associated protein-protein interactions in metabolic syndrome: a recent update","volume":"124","author":"Verma","year":"2023","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135948","article-title":"PI3K, mTOR and GSK3 modulate cytokines\u2019 production in peripheral leukocyte in temporal lobe epilepsy","volume":"756","author":"Vieira","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"9596","key":"10.1016\/j.jneuroim.2026.578931_bb0475","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578931_bb0480","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.fertnstert.2014.01.027","article-title":"Urinary cytokine and chemokine profiles across the menstrual cycle in healthy reproductive-aged women","volume":"101","author":"Whitcomb","year":"2014","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578931_bb0485","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2014.03.024","article-title":"Decreased interleukin-10 serum levels in first-episode drug-na\u00efve schizophrenia: relationship to psychopathology","volume":"156","author":"Xiu","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jneuroim.2026.578931_bb0490","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbi.2016.03.005","article-title":"Contribution of IL-10 and its \u2212592 a\/C polymorphism to cognitive functions in first-episode drug-naive schizophrenia","volume":"57","author":"Xiu","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578931_bb0495","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cyto.2012.02.013","article-title":"Monocyte chemoattractant protein-1 in schizophrenia: -2518A\/G genetic variant and protein levels in armenian population","volume":"58","author":"Zakharyan","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2026.578931_bb0500","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpsycho.2017.02.001","article-title":"Increased ratio of high sensitivity c-reactive protein to interleukin-10 as a potential peripheral biomarker of schizophrenia and aggression","volume":"114","author":"Zhang","year":"2017","journal-title":"Int. J. Psychophysiol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826000792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826000792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:55:04Z","timestamp":1784552104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826000792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":100,"alternative-id":["S0165572826000792"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.578931","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional immune responses to PI3K pathway inhibition in PBMCs from schizophrenia patients without metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.578931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"578931"}}